ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 48 filers reported holding ALPINE IMMUNE SCIENCES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $274,720 | +153.1% | 23,993 | +127.2% | 0.00% | – |
| Q2 2023 | $108,547 | +59.9% | 10,559 | +20.0% | 0.00% | – |
| Q1 2023 | $67,905 | +2.2% | 8,796 | -2.7% | 0.00% | – |
| Q4 2022 | $66,429 | +51.0% | 9,038 | +46.6% | 0.00% | – |
| Q3 2022 | $44,000 | -22.8% | 6,165 | -7.7% | 0.00% | – |
| Q2 2022 | $57,000 | +26.7% | 6,679 | +34.5% | 0.00% | – |
| Q1 2022 | $45,000 | -47.1% | 4,967 | -19.2% | 0.00% | – |
| Q4 2021 | $85,000 | +28.8% | 6,150 | -1.0% | 0.00% | – |
| Q3 2021 | $66,000 | -54.5% | 6,215 | -61.5% | 0.00% | – |
| Q2 2021 | $145,000 | – | 16,137 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,571,450 | $27,257,000 | 2.19% |
| Omega Fund Management, LLC | 1,284,900 | $13,620,000 | 1.29% |
| Samsara BioCapital, LLC | 399,190 | $4,231,000 | 0.78% |
| Soleus Capital Management, L.P. | 313,064 | $3,318,000 | 0.60% |
| Avidity Partners Management LP | 1,511,000 | $16,017,000 | 0.44% |
| Dorsey Wright & Associates | 3,380 | $35,828,000 | 0.42% |
| EcoR1 Capital, LLC | 741,290 | $7,858,000 | 0.35% |
| Orbimed Advisors | 3,070,955 | $32,552,000 | 0.30% |
| TIGER MANAGEMENT L.L.C. | 137,728 | $1,460,000 | 0.29% |
| DAFNA Capital Management LLC | 113,302 | $1,201,000 | 0.28% |